Erionite and asbestos differently cause transformation of human mesothelial cells

International Journal of Cancer

Volumn 121, Issue 1, 2007, Pages 12-20

  Bertino, P ^a   Marconi, A ^b   Palumbo, L ^b   Bruni, B M ^b   Barbone, D ^a   Germano, S ^a   Dogan, A U ^c,d   Tassi, G F ^e   Porta, C ^f   Mutti, L ^g   Gaudino, G ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c ANKARA UNIVERSITY   (Turkey)

^d IA United States   (United States)

^e Brescia Civic Hospital   (Italy)

^f FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^g Local Health Unit   (Italy)

Author keywords

Asbestos; Cell transformation; Erionite; Mesothelioma; Zeolite

Indexed keywords

ASBESTOS; CYCLIN D1; CYCLIN E; ERIONITE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; UNCLASSIFIED DRUG; ZEOLITE;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; GROWTH RATE; HUMAN; HUMAN CELL; MESOTHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN VIRUS 40;

ASBESTOS; CELL DEATH; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYTOTOXINS; DNA; DNA DAMAGE; EPITHELIUM; HUMANS; MICROSCOPY, ELECTRON, SCANNING; TIME FACTORS; ZEOLITES;

EID: 34248578192     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22687     Document Type: Article

References (42)

1. Mossman BT, Gee JB. Asbestos-related diseases. N Engl J Med 1989;320:1721-30.
2. Mossman BT, Kamp DW, Weitzman SA. Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest 1996;14:466-80.
3. Dogan AU, Dogan M, Emri S. Erionite. In: Wexler P. (ed.), Encyclopedia of toxicology, 2nd edn., vol. 2. Oxford: Elsevier, 2005;237-41.
4. Dogan AU, Baris YI, Dogan M, Emri S, Steele I, Elmishad AG, Carbone M. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res 2006;66:5063-8.
5. Okayasu R, Wu L, Hei TK. Biological effects of naturally occurring and man-made fibres: in vitro cytotoxicity and mutagenesis in mammalian cells. Br J Cancer 1999;79:1319-24.
6. Carthew P, Hill RJ, Edwards RE, Lee PN. Intrapleural administration of fibres induces mesothelioma in rats in the same relative order of hazard as occurs in man after exposure. Hum Exp Toxicol 1992;11:530-4.
7. Eborn SK, Aust AE. Effect of iron acquisition on induction of DNA single-strand breaks by erionite, a carcinogenic mineral fiber. Arch Biochem Biophys 1995;316:507-14.
8. Poole A, Brown RC, Turver CJ, Skidmore JW, Griffiths DM. In vitro genotoxic activities of fibrous erionite. Br J Cancer 1983;47:697-705.
9. Wagner JC, Skidmore JW, Hill RJ, Griffiths DM. Erionite exposure and mesotheliomas in rats. Br J Cancer 1985;51:727-30.
10. Long JF, Dutta PK, Hogg BD. Fluorescence imaging of reactive oxygen metabolites generated in single macrophage cells (NR8383) upon phagocytosis of natural zeolite (erionite) fibers. Environ Health Perspect 1997;105:706-11.
11. Janssen YM, Heintz NH, Marsh JP, Borm PJ, Mossman BT. Induction of c-fos and c-jun proto-oncogenes in target cells of the lung and pleura by carcinogenic fibers. Am J Respir Cell Mol Biol 1994;11:522-30.
12. Timblin CR, Guthrie GD, Janssen YW, Walsh ES, Vacek P, Mossman BT. Patterns of c-fos and c-jun proto-oncogene expression, apoptosis, and proliferation in rat pleural mesothelial cells exposed to erionite or asbestos fibers. Toxicol Appl Pharmacol 1998;151:88-97.
13. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:1911-2.
14. Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H, Haga N. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci 2003;94:15-21.
15. Waddick KG, Uckun FM. Innovative treatment programs against cancer. II. Nuclear factor-κB (NF-κB) as a molecular target. Biochem Pharmacol 1999;57:9-17
16. Berken A, Abel J, Unfried K. β1-integrin mediates asbestos-induced phosphorylation of AKT and ERK1/2 in a rat pleural mesothelial cell line. Oncogene 2003;22:8524-8.
17. Janssen YM, Barchowsky A, Treadwell M, Driscoll KE, Mossman BT. Asbestos induces nuclear factor κ B (NF-κ B) DNA-binding activity and NF-κ B-dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci USA 1995;92:8458-62.
18. Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z, Bubici C, Mossman BT, Pass HI, Testa JR, Franzoso G, Carbone M. TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci USA 2006;103:10397-402.
19. Pache JC, Janssen YM, Walsh ES, Quinlan TR, Zanella CL, Low RB, Taatjes DJ, Mossman BT. Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers. Am J Pathol 1998;152:333-40.
20. Bermudez E, Everitt J, Walker C. Expression of growth factor and growth factor receptor RNA in rat pleural mesothelial cells in culture. Exp Cell Res 1990;190:91-8.
21. Cacciotti P, Libener R, Betta P, Martini F, Porta C, Procopio A, Strizzi L, Penengo L, Tognon M, Mutti L, Gaudino G. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci USA 2001;98:12032-7.
22. Tolnay E, Kuhnen C, Wiethege T, Konig JE, Voss B, Muller KM. Hepatocyte growth factor/scatter factor and its receptor c-Met are over-expressed and associated with an increased microvessel density in malignant pleural mesothelioma. J Cancer Res Clin Oncol 1998;124:291-6.
23. Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa JR, Pass HJ, Rizzo P, Carbone M. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci USA 2000;97:10214-19.
24. Cacciotti P, Barbone D, Porta C, Altomare DA, Testa JR, Mutti L, Gaudino G. SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure. Cancer Res 2005;65:5256-62.
25. Emri S, Kocagoz T, Olut A, Gungen Y, Mutti L, Baris YI. Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey. Anticancer Res 2000;20:891-4.
26. De Rienzo A, Tor M, Sterman DH, Aksoy F, Albelda SM, Testa JR. Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey. J Cell Biochem 2002;84:455-9.
27. Mumpton FA. A reconnaissance study of the association of zeolites with mesothelioma occurrences in central Turkey, United States Department of the Interior Geological Survey, 1979.
28. Dogan M. Sources and types of mineral dust in regions of Turkey with endemic malignant mesothelioma. Indoor Built Environ 2003;12:377-83.
29. Dogan M, Dogan AU. Asbestos mineralogy and health effects. In: Pass HI, Vogelzang NJ, Carbone M. (eds.), Malignant mesothelioma: advances in pathogenesis, diagnosis, and translation therapies. New York: Springer, 2005, 209-25.
30. Kohyama N, Shinohara Y, Suzuki Y. Mineral phases and some reexamined characteristics of the International Union Against Cancer standard asbestos samples. Am J Ind Med 1996;30:515-28.
31. Mossman BT. In vitro approaches for determining mechanisms of toxicity and carcinogenicity by asbestos in the gastrointestinal and respiratory tracts. Environ Health Perspect 1983;53:155-61.
32. Toyokuni S, Sagripanti JL. Association between 8-hydroxy-2′- deoxyguanosine formation and DNA strand breaks mediated by copper and iron. Free Radic Biol Med 1996;20:859-64.
33. Kueng W, Silber E, Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem 1989;182:16-9.
34. Wright WE, Rom WN, Moatamed F. Characterization of zeolite fiber sizes using scanning electron microscopy. Arch Environ Health 1983;38:99-103.
35. Stanton MF, Laynard M, Tegeris A, Miller E, May M, Kent E. Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst 1977;58:587-603.
36. Becher R, Hetland RB, Refsnes M, Dahl JE, Dahlman HJ, Schwarze PE. Rat lung inflammatory responses after in vivo and in vitro exposure to various stone particles. Inhal Toxicol 2001;13:789-805.
37. Johnson NF, Edwards RE, Munday DE, Rowe N, Wagner JC. Pluripotential nature of mesotheliomata induced by inhalation of erionite in rats. Br J Exp Pathol 1984;65:377-88.
38. Davis JM, Bolton RE, Miller BG, Niven K. Mesothelioma dose response following intraperitoneal injection of mineral fibres. Int J Exp Pathol 1991;72:263-74.
39. Kamp DW, Graceffa P, Pryor WA, Weitzman SA. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 1992;12:293-315.
40. Marchevsky AM, Wick MR. Current controversies regarding the role of asbestos exposure in the causation of malignant mesothelioma: the need for an evidence-based approach to develop medicolegal guidelines. Ann Diagn Pathol 2003;7:321-32.
41. Maples KR, Johnson NF. Fiber-induced hydroxyl radical formation: correlation with mesothelioma induction in rats and humans. Carcinogenesis 1992;13:2035-9.
42. Mayall FG, Jacobson G, Wilkins R. Mutations of p53 gene and SV40 sequences in asbestos associated and non-asbestos-associated mesotheliomas. J Clin Pathol 1999;52:291-3.